GLP-1 Treatment Users: Interview on Weight Management and Diabetes Care

What We're Researching We're running a paid study on the real-world experiences of patients using GLP-1 treatments like Ozempic, Wegovy, or Mounjaro. This research helps us understand the practical realities of managing weight and diabetes care through these specific medications. We want to map out the challenges and successes patients face in their daily lives. How It Works You will participate in a remote video interview to walk us through your personal journey with GLP-1 treatments. We will ask you to detail your daily routines, how you manage your dosage, and any lifestyle adjustments you have made. You will also react to various discussion prompts about your overall healthcare experience. The conversation flows as an open dialogue focused entirely on your individual perspective. Who This Is For We welcome individuals who have firsthand experience taking GLP-1 medications for either weight management or diabetes care. Whether you recently started your treatment or have been managing your care for years, your perspective is valuable to us. We are looking for candidates who are comfortable speaking openly about their health routines and medication schedules. What You'll Do Describe your personal history and experience with GLP-1 medications Walk us through your daily routine and how you manage your medication schedule Discuss the lifestyle changes or adjustments you have made alongside your treatment Share your thoughts on the overall effectiveness and challenges of your care plan Who Should Apply Personal experience using a GLP-1 treatment (such as Ozempic, Wegovy, or Mounjaro) Using the medication for weight management or diabetes care Comfortable discussing personal health routines in a one-on-one setting Ability to join a remote video call from a quiet environment Compensation $40 one-time Ready to participate? Start your paid interview now About Terac Terac is building the world's largest pool of vetted human experts for AI. Researchers, AI labs, and product